<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Ltd has informed stock exchanges that it does not qualify as a 'Large Corporate' under SEBI's October 2023 circular, so the Initial Disclosure requirement for FY 2025-26 does not apply to the company. To be classified as a Large Corporate, a listed entity must meet all three conditions: being listed on a recognized stock exchange, having outstanding long-term borrowings of Rs. 1,000 crore or more, and holding an 'AA'/'AA+'/ 'AAA' credit rating on unsupported bank borrowings or plain vanilla bonds. Anuh Pharma meets only the first condition (its equity shares are listed on BSE and NSE) but does not meet the borrowing or credit rating thresholds. As a result, no further disclosure filing is required under this framework for the current financial year.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms the company is too small in terms of borrowings and credit profile to fall under SEBI's Large Corporate disclosure framework, suggesting conservative leverage and a modest scale of operations relative to larger listed peers.